• Pattern of investigating transmission pathways and etiologic agents in epidemic hepatitis, spanning waterborne outbreaks, syringe- and transfusion-associated spread, and early transmission experiments to characterize routes and causative agents [2] [10] [8] [7] [15].

• Immunoprophylaxis using human gamma globulin emerged as a central preventive strategy, with early demonstrations and later refinements showing attenuation and prevention of infectious hepatitis in at-risk populations [3] [13].

• Clinical follow-up and pathological inquiry shifted focus to chronicity and sequelae after acute infectious hepatitis, documenting persistent disease, late residuals, and chronic hepatitis phenotypes across Mediterranean and subsequent cohorts [4] [20] [11].

• Descriptive pathology and spectrum characterization of epidemic hepatitis defined a disease entity prior to etiologic isolation, including fulminant forms and classic pathology descriptions guiding later etiologic work [12] [5] [16].